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Summary  
Cytokines are potent regulators of the chondrocyte functions. Some of them are produced by chondrocytes and interact 
to regulate cartilage metabolism. In this study, we investigated the production of interleukin-lfl (IL-lfl), IL-6, IL-8 and 
leukemia inhibitory factor (LIF) by human chondrocytes and examined the modulation of their secretion by exogenous 
cytokines. Human articular chondrocytes were isolated from their extracellular matrix by a triple successive enzymatic 
digestion of the cartilage. Subsequently, chondrocytes were stimulated by increased amounts of human recombinant 
cytokines [IL-lfl, tumour necrosis factor ~ (TNF~), IL-8, LIF, IL-6]. ILl/?, IL-6, IL-8 and LIF were assayed into culture 
media and inside cell extracts by specific enzyme amplified sensitivity immunoassays (EASIAs). Under these 
experimental conditions, we have identified various interactions between cytokines. IL-~ and TNFa highly stimulated 
IL-6, LIF and IL-8 productions. IL-6 decreased IL-8 synthesis and increased LIF production. IL-8 slightly enhanced IL-6 
production. Finally, LIF stimulated IL-lfl, IL-6 and IL-8 productions. Using neutralizing antibodies against I L l ,  we 
demonstrated that the effects of LIF were secondary to the stimulation by LIF of IL-lfl production by the chondrocytes. 
In conclusion, chondrocytes secrete a variety of immunocompetent cy okines including IL-lfl, IL-6, IL-8 and LIF that 
can interact o regulate chondrocytes metabolism. These results also define new biological activities of LIF and IL-6, 
and raise questions concerning their role in the pathogenesis of joint diseases. 
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Introduct ion 
IN VIEW of their  presence in synovial fluid, various 
cytokines such as inter leukin (IL-lfl), tumour  
necrosis factor (TNFa) ,  IL-6, IL-8 and leukemia 
inhib i tory factor  (LIF) [1, 2, 3] are l ikely to be 
involved in the pathogenesis of destruct ive joint 
disorders. Cytokines are produced transient ly  in 
response to an act ivat ing signal and all cells, 
including chondrocytes,  can produce some cytoki- 
nes. These cytokines produced by chondrocytes 
may exert their  effects on ne ighbour ing cells or 
tissues, as a paracr ine manner  or on producing 
cells themselves, as an autocr ine manner. TNF~ 
and IL-lfl are identif ied as potent  act ivators of 
chondrocytes playing a pivotal role in the etiology 
of cart i lage degenerat ion.  In response to these 
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cytokines, chondrocytes tart  secret ing neutra l  
metal loprote inases [4, 5] and active oxygen species 
[6, 7] which are efficient factors in cart i lage matr ix 
destruct ion.  Moreover, these cytokines inhibit  
proteoglycan [8] and col lagen syntheses [9], 
markedly reducing cart i lage repair  capacit ies. 
Both cytokines may also st imulate bone resorpt ion 
[10] and induce a t rans ient  inf lammation and 
leukocyte inf i l trat ion of the synovial membrane 
[11]. Currently,  it is suggested that TNF  and IL-1 do 
not  act in isolat ion and that  their  effects are often 
the result  of an interact ion of various cytokines 
including IL-6, IL-8 and LIF [12]. 
IL-6 is a potent  B-cell growth factor  and 
di f ferent iat ion factor  [13]. Therefore, through 
augmentat ion of rheumato id  factor and other  
autoant ibodies in the synovium, it could indirect ly  
exacerbate inf lammation. Moreover, it also induces 
acute phase proteins synthesis such as C-reactive 
protein (CRP) and serum amyloid A (SAA) [14]. The 
effects of IL-6 on chondrocytes are still unclear.  No 
effect [15], sl ight enhancement  [16] as well as 
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depression [17] of proteoglycan synthesis has been 
reported. Production of tissue inhibitor of metallo- 
proteinases (TIMP) [18] and transforming rowth 
factor (TGFfl) [19] is stimulated by IL-6. In this role, 
IL-6 could be a moderator of the cartilage 
resorption processes. Because chondrocytes have 
been shown to proliferate in response to IL-6 [20], 
IL-6 could also be involved in cartilage early repair 
reaction occurring in osteoarthritis. 
IL-8 is one of the most important chemotactic 
factors for neutrophils and T lymphocytes [21]. IL-8 
also induces neutrophil degranulation, and thus 
may participate in cartilage degradation [22]. No 
direct effects of IL-8 on chondrocytes metabolism 
have been described. 
Currently, the role played by LIF in the 
pathogenesis of joint diseases is not well under- 
stood. LIF was initially described on the basis of its 
ability to induce differentiation of murine myeloid 
leukemic cells [23]. It inhibits differentiation of 
pluripotent embryonic stem cells [24], induces the 
synthesis of hepatic acute phase proteins [25], 
promotes neuronal differentiation [26], inhibits 
lipoprotein lipase [27], increases neuronal sub- 
stance P expression [28] and regulates bone 
metabolism [29, 30]. The role played by LIF in the 
homeostasis of cartilage remains unclear. 
It is now recognized that cytokines exhibit both 
pleiotropy and redundancy and that differing 
cytokines exhibit both synergically and antagon- 
istically. Some recent papers have reported that 
IL-lfl stimulates IL-6, IL-8, and LIF productions 
[31, 32]. Whether these cytokines are capable of 
feed back control of cytokines released remains 
largely uninvestigated. Therefore, we decided to 
systematically research interactions existing be- 
tween those cyt0kines produced by chondrocytes 
themselves. 
Materials and methods  
SHORT-TERM SUSPENSION CULTURE OF HUMAN 
CHONDROCYTES 
Chondrocytes were cultured for a short period in 
order to maintain their phenotype. In this method, 
we used cartilage obtained from the knee joints of 
normal young adults shortly after death. Avoiding 
the calcified layer, cartilage slices were excised 
from the superficial and medium layers of cartilage, 
cut into small fragments and submitted to 
enzymatic digestion. Cartilage fragments were 
sequentially treated by hyaluronidase, pronase and 
collagenase. Cartilage pieces were incubated with 
hyaluronidase dissolved in Dulbecco's Modified 
Eagle's Medium (DMEM, ICN Biomedical) (0.5 rag/ 
ml-3 g cartilage per 10ml enzyme solution) for 
30 min at 37°C and constantly agitated (200 rpm). 
Cartilage fragments were then put into pr0nase 
solution (1 mg/ml in DMEM-3 g per 10 ml enzy- 
matic solution) and incubated I h at 37°C and 
subsequently re-incubated, under constant agita- 
tion (200 rpm), with collagenase (1 mg/ml-3 g per 
10ml enzyme solution) dissolved in DMEM 
containing 1% Ultroser G (Gibco, Gent, Belgium) 
for 20 h at 37°C. Ultroser G is a serum substitute 
which replaces fetal calf serum in in vitro culture. 
The biological activity of the reconstituted 
solution is fivefold that of fetal calf serum. Cells 
were then filtered through 25 pm nylon mesh, 
washed three times, counted (ranged among 
1-1.5 106 cells/ml) and seeded in 10 ml polypropy- 
lene Falcon flasks. Chondrocytes were cultured in 
DMEM containing 1% Ultroser G. Cells were 
maintained in suspension by constant agitation on 
a giratory shaker (100 rpm) in an atmosphere of 
95% air 5% CO2. Cells and supernatant were 
separated by centrifugation (1000 rpm, 5 min). The 
cell viability, estimated by trypan blue incorpor- 
ation, was 95%. Culture media were directly 
assayed for cytokines. Cell pellets were washed 
twice with HBSS (Hank's Buffer Saline Solution, 
Gibco, Merelbeeke, Belgium) and then homogen- 
ized in PBS pH 7.5 by ultrasonic dissociation (10 s 
pulses, power 50 W/cm 2) at 4°C. 
TREATMENTS 
Human recombinant IL-lfl was purchased from 
Boehringer (Boehringer Mannheim, Mannheim, 
Germany) and used at concentrations ranging 
from 50 to 2500 units per ml (specific activity 
about 5× 107 U/rag) corresponding respectively to 
0.58 x 10-1°-2.9 × 10 -9 M. According to the manufac- 
turer specifications, IL-lfl preparation was free of 
endotoxin. 
Human recombinant TNF~ was purchased from 
Boehringer (Boehringer Mannheim, Mannheim, 
Germany) and  tested at concentrations from 
2-100 ng/ml corresponding to 1.17 x 10-1°-5.9× 
10-gM. The specific activity was superior at 1× 
10 ~. One unit was defined as the amount of TNFa 
that was required to mediate half-maximal cy- 
toxicity with WEHI 164 cells in the presence of 
actinomycin. Endotoxin, evaluated by Limulus 
Amebocyte Lysate test (LAL-test) was < 10 EU/ml. 
Human recombinant IL-6 was kindly provided by 
SANDOZ (Basel, Switzerland) and used at concen- 
trations of 100, 1000 and 10000U/ml which 
corresponded, respectively, to 2, 20 and 200 ng/ml. 
Specific activity was 52× 106 U/mg. According to 
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the  manufacturer  specif ications, endotox in  was not  
detectable in the IL-6 preparat ion .  
Human recombinant  IL-8 (SANDOZ, Basel, 
S~i tzer land)  was used at concentrat ions  ranged 
a~ong 0.8-80 ng/ml  cor respond ing  to 1 x 10 -~°- 
t:}~0~:M. The absence of endotox in  was verif ied by 
LAL~test. 
Human recombinant  L IF  was obta ined from 
PeProtech  (Rocky Hill, U.S.A.) and added to the 
cu l ture  med ium at concentrat ions  from 8-800 U/ml. 
Specific act iv i ty  cor responded at 4x l0~U/mg.  
Thes e concentrat ions  cor responded respect ively 
at 10-u -10-~.  The preparat ion  was endotox in  
: free. :~ 
Rabbi t  ant i serum (purif ied IgGs) neutra l i z ing  
iL-lf l  and a act iv it ies was purchased from 
Calb iochem (La Jol ia,  U.S.A.). One mi l l ig ram of 
puri f ied IgG neutra l i zed 10 000U of IL-lf l .  Anti- 
bodies were added into cu l ture med ium at 
concentrat ions  of 10 and 50 gg/ml. 
Puri f ied polyclonal  ant ibodies neutra l i z ing 
L IF  act iv i t ies were a gift of Dr A. Godard  
(Univers i ty of Nantes,  France).  Ten micrograms of 
these ant ibodies neutra l i zed 2.5 ng of LIF. 
Three cu l ture flasks were used for each concen- 
t rat ion  of cytok ine as well as for the cor respond ing 
controls.  Each cu l ture was run  wi th  chondrocytes  
f rom the knee jo int  of a single pat ient.  
IMMUNOASSAYS FOR CYTOKINES AND DNA ASSAY 
IL-lfl, IL-6, IL-8 and L IF  were assayed in the 
cu l ture med ium and in the cor respond ing cel lu lar  
phase by specific EAS IA  (Enzyme Ampli f ied 
Sensit iv i ty Immunoassay)  k indly provided by 
Medgenix  (Fleurus,  Belgium). Results  were 
expressed in pg/ml. The methods used, type of 
tracer, sensitivity, precis ion,  reproducib i l i ty  and 
accuracy  have been prev ious ly  descr ibed [33]. 
Chondrocyte  DNA content  was measured  accord- 
ing to the f luor imetr ic  method of Labarca  and 
Paigen [34]. 
CALCULATION AND STATISTICAL ANALYSIS 
The results  were expressed as amounts  of 
cytokines measured  in the cul ture med ium per pg 
of DNA and as cel lu lar  phase content  per  /zg of 
DNA. Tota l  cytok ine product ions  were also 
ca lcu lated by adding the amount  found in the 
cul ture med ium and wi th in  the cor respond ing 
cel lu lar  phase. The mean +_ S.D. of each var iable 
was calculated.  Compar i son  of mean values was 
per formed us ing the unpa i red  Student 's  t-test, with 
a l imit of s igni f icat ion at P < 0.05. P roduct ion  
curves for each exper imenta l  condi t ion were 
compared  by means  of Zerbe's randomizat ion  test  
[35]. This test  is based on an approx imate  F test  
wi th  degree of f reedom approx imat ion  that  de- 
pends on both  observat ions  and t ime interva l  
considered.  Di f ferences were cons idered statisti-  
cal ly s igni f icant when P < 0.05. 
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FIG. 1. Effect of human recombinant tumour necrosis 
factor-a (TNF~) on IL-6 (a), IL-8 (b) and LIF (c) amounts 
produced and released into culture medium by human 
chondrocytes. Cytokines levels were measured after 24, 
48 and 72 h of treatment with increased amounts of 
TNF~. The data are expressed as amounts of cytokines 
found into culture per gg of DNA and presented as 
the mean and standard deviation (S.D.) of triplicate 
cultures. Statistical significance: *P < 0.05; **P < 0.01; 
• **P < 0.001. 
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Results 
EFFECT OF TNFg ON CYTOKINE PRODUCTION 
Cytokines released into culture med ium 
I1-6, IL-8 and LIF amounts  re leased in the cu l ture 
medium by unst imulated chondrocytes increased 
progressively as a funct ion of the cu l ture period. 
Nevertheless, analysis of the t ime courses 
suggested that  a high rat io of the IL-6 and IL-8 
product ion occurred in first 24 h of the culture. 
When chondrocytes were cu l tured in the presence 
of TNFa,  regardless of the TNFa  dose (2, 20 and 
100 ng/ml) and culture period (24, 48 or 72h) 
[Fig. l(a), (b), (c)] cytokine amounts  measured in 
cul ture media were signif icantly h igher  than  
control  values (0.05 < P < 0.001). This st imulat ing 
effect of TNF~ was dose-dependent for IL-8 
product ion (0.95 < P < 0.98; P < 0.01) whichever 
the cu l ture  period considered [Fig. l(b)]. Concern- 
ing IL-6 product ion,  the st imulat ion was only 
dose-dependent after 24 and 48h of cu l ture 
(0 .65<r<0.84;  0 .05<P<0.001) .  As shown by 
Fig. l(c), unst imulated chondrocytes did not 
produce detectable amounts  of L IF  dur ing the first 
24 h of culture. Nevertheless, L IF  product ion was 
signif icantly increased by TNFa.  
Cytokines content inside cell pellets 
Table I shows amounts of cytokine measured 
in the cel lu lar  phase as a funct ion of the cu l ture 
time. It appears that  cytokine levels present  in 
the cel lu lar  phase reached a maximum after 24 h 
and then decreased asa  funct ion of cu l ture 
period. We observed also that  cytokine levels in the 
cel lu lar  phase were lower than  amounts  found in 
the cu l ture medium. TNF~ signif icantly increased 
the level of IL-8 content  in the cel lu lar  phase. 
Responses were dose-dependent at each cu l ture  
t ime studied (0.95 < r < 0.98; 0.01 < P < 0.001). 
IL-6 content  was also enhanced by TNFa  
(P < 0.01 < P < 0.05). In our  cul ture and assay 
condit ions, L IF  was not  detectable in the cel lu lar  
phase. 
EFFECT OF IL-1)~ ON CYTOKINE PRODUCTION 
Fig. 2 shows the total  IL-6, IL-8 and L IF  
product ion (sum of cytokine amounts  re leased in 
the cul ture medium and with in the corresponding 
cel lular phase) after 72 h of cu l ture with or w i thout  
IL-lfl. Total  cytokine product ions were near ly  
equal to the cytokine amounts  re leased into 
cul ture medium after  72 h. Less than 5% of the 
total  cytokine product ion was present in the 
cel lular phase at day 3. IL-lfl induced a h ighly 
signif icant increase of the total  IL-6, IL-8 and L IF  
product ion (P< 0.001; Fig. 2). Responses were 
dose-dependent for IL-8 (r = 0.90) and LIF (r = 0.71) 
productions. 
EFFECT OF IL-6 ON CYTOKINE PRODUCTION 
During the first 48 h of incubation,  IL-6 did 
not signif icantly affect the total  IL-8 product ion  
by human chondrocytes.  When cu l ture t ime 
was prolonged unti l  72h, IL-6 decreased IL-8 
product ion whatever the concentrat ion  studied 
(2, 20 or 200ng/ml; 0.001 <P< 0.01; Fig. 3). 
IL-6 also enhanced LIF amounts secreted and 
released into cul ture medium by chondrocytes 
(Fig. 4). After 72 h of culture, the effect was 
signif icant at each concentrat ion of IL-6 tested 
(0.01 < P < 0.05). 
Table I. 
IL-6 and IL-8 levels measured inside chondrocytes after 24, 48 and 72 h of culture with 
or without increased amounts of TNFc~ 
Culture duration 
and parameters TNFa TNF~ TNF~ 
study Control 2 ng/ml 20 ng/ml 100 ng/ml 
IL-6 pg/#g DNA 
24 h 12.1 ± 0.85 12.6 i 0.85 16.4 ± 2.64 21.3 ± 3.05* 
48 h 4.35 i 0.57 7.91 i 1.12" 11.4 i 1.92" 10.2 ± 1.2" 
72 h 3.03 ± 0.27 4.91 i 0.66* 5.63 ± 0.53* 5.81 ± 0.3** 
IL-8 pg/#g DNA 
24 h 17.9 ± 3.9 42 i 3.5** 65 i 11"* 114 i 14"* 
48 h 15.6 i 2.0 39 ± 5.0** 62.5 i 5.8*** 110 ± 7.6** 
72 h 14 i 1.0 35 i 1.4"** 60 i 8.6** 76 i 10"* 
Values are the means of three separate determinations and are expressed as amounts of cytokines 
present inside cells per #g of DNA. *Statistically significant difference compared with the controls 
*P < 0.05; **P < 0.01; ***P < 0.001. 
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FIG. 2. Total amounts (sum of the amount found within 
culture medium and inside cellular phase) of (a) IL-6, (b) 
IL-8 and (c) LIF produced by human chondrocytes 
cultured for 72 h in the absence or presence of increased 
doses of II~lfl. Results are expressed as mean values of 
three cultures from the same donor. Responses are 
significant ***P < 0.001. 
EFFECT OF IL -~ ON CYTOKINE PRODUCTION 
At the concentration of 80 ng/ml, IL-8 slightly 
increased the amount of IL-6 released in .the 
culture medium (P < 0.05; Table II). The effect was 
present after 48 and 72 h of culture. IL-8 had no 
significant effect on IL-6 content in the cellular 
phase. However, IL-8 had no effect on LIF 
production either in the cellular phase or in the 
culture medium (data not shown). 
EFFECT OF L IF  ON CYTOKINE PRODUCTION 
The time course analysis of IL-6 production 
shows that the IL-6 released in the culture medium 
continuously increased as a function of the culture 
period with or without the addition of LIF (Fig. 5). 
However, the curves obtained for the highest 
concentrations of LIF (2 and 20ng/ml) were 
significantly higher than the control curve show- 
ing a stimulation. No effect was observed at the 
concentrat ion of 0.2 ng/ml. The amount of IL-6 
found in cellular phase rapidly increased during 
the first 24 h of culture and progressively decreased 
as a function of culture duration. LIF increased 
significantly the IL-6 content at the doses of 2 and 
20 ng/ml (Fig. 5). 
LIF also stimulated total IL-8 production (Fig. 6). 
In the presence of 20 ng/ml of LIF, stimulation was 
already significant after 12 h. In our culture and 
assay conditions, unstimulated chondrocytes did 
not spontaneously produce IL-lfl. Interestingly, the 
production of IL-lfl rapidly increased with the 
addition of LIE These results suggested that LIF 
effects on IL-6 and IL-8 productions could be 
secondarily mediated by IL-lfl. To verify this 
hypothesis, we simultaneously cultured chondro- 
cytes with LIF and antibodies neutralizing IL-I~ 
and ft. Surprisingly, 5 and 10pg of neutral iz ing 
antibodies added into culture medium inhibited 
the spontaneous production of IL-6. Neutral izing 
IL-la and fl activities antibodies, totally inhibited 
the stimulating effect of LIF on IL-6 production 
(Fig. 7). Similar results were obtained on IL-8 
production (data not shown). 
EFFECT OF POLYCLONAL ANT IBODIES  (PAB L IF)  
NEUTRAL IZ ING L IF  ACT IV ITY  ON CYTOKINE 
PRODUCTION 
When human art icular chondrocytcs were cul- 
tured for 72 h in the presence of antibodies 
neutralizing LIF activity, IL-6 production was 
significantly decreased (Table III). On the other 
hand, IL-8 produced by chondrocytes was slightly 
decreased as compared with the controls. In the 
presence of IL-lfl (17 ng/ml), the cytokines pro- 
duction was markedly enhanced (0.01 < P < 0.001). 
When IL-lfl and LIF Pab were simultaneously 
added in the culture medium, the stimulating effect 
of IL-lfl was not significantly modified. These data 
suggest that LIF had no effect upon the IL-lfl 
activity. 
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Fro. 3. Human chondrocytes were incubated for the time specified in the absence or presence of varying concentrations 
of human recombinant interleukin(IL-6). At the end of the period, supernatant and cells were separated by 
centrifugation a d were assayed for interleukin (IL-8) by a specific EASIA. The values correspond to the total amount 
of IL-8 (sum of the amount found inside cellular phase and within culture medium) produced by chondrocytes. After 
72 h of incubation, IL-6 significantly decreased IL-8 production as compared with the control values. Responses are 
significant with a ***P < 0.001. 
Discuss ion 
The data presented in this paper show that 
freshly isolated human chondrocytes can spon- 
taneously secrete IL-6, IL-8 and LIF. It is now 
accepted that these cytokines mediate a variety of 
activities on immunocompetent cells and connec- 
tive tissues. Nevertheless, regulator effects of these 
cytokines on the other cytokine production are 
still obscure and not well documented. In the 
present work, we have identified some regulator 
pathways existing between IL-lfi, IL-6, IL-8 and 
LIF. These regulator pathways may play an 
important part in the maintenance of the dynamic 
equilibrium between synthesis and degradation i  
cartilage as well as in the pathogenesis of joint 
disease. 
We have demonstrated that IL-lfl and TNFa 
are potent stimulators of IL-6, IL-8 and LIF 
production. The presence of high levels of these 
cytokines in the synovial fluid of patients with 
rheumatoid arthrit is (RA) suggests that they may 
participate in the joint destruction in RA [1, 2, 3]. 
Under our culture conditions, the levels of 
IL-lfl that induced IL-6 and IL-8 were in the 
same range of concentrations as those found 
in RA synovial fluid. This• finding suggests that 
stimulated chondrocytes are an important source 
of cytokines that may contribute, at least par- 
tially, to the enhancement of the cytokine levels 
observed in joint diseases. Interestingly, our results 
also provide evidence that chondrocytes could be 
an important reservoir of IL-8. This finding 
suggests those chondrocytes have the potential 
to initiate and propagate inflammation through 
their ability to rapidly release in the extracellular 
environment a high level of the potent neutrophils- 
activating cytokine. By this way, chondrocytes 
may act on neighbouring tissues and participate 
in the development of synoviotis and bone 
remodelling present in RA. Although the role 
played by IL-lfl and TNF~ in the pathogenesis 
of joint diseases is clearly demonstrated, the 
actions of IL-6, IL-8 and LIF require further 
examination. 
Because qually high amounts were found in the 
supernatant of chondrocytes culture stimulated 
with IL-lfl, we tested human recombinant IL-6 at 
concentrations ranging from 2-200 ng/ml. In this 
concentration range, IL-6 induced a depression of 
IG8 production and a stimulation of LIF synthesis. 
In light of the biological functions of IL-8, the 
inhibition of this cytokine suggests a negative 
feedback regulation to limit inflammatory reaction 
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Fro. 4. Leukemia inhibitory factor (LIF) amount released within culture medium as a function of culture duration. 
Interleukin-6 (IL-6) added into culture medium at concentrations ranging from 2-200 ng/ml increased LIF amount 
produced by human chondrocytes. Significant effects were observed after 48 h of culture at the concentrations of 20 
and 200 ng/ml and for each concentration used after 72 h of culture. Statistical significance: *P < 0.05; **P < 0.01. 
and joint invasion by neutrophi ls  and T lympho- 
cytes. Indeed, it ±snow well established that  IL-8 is 
one of the most potent  chemoatt ractant  factors for 
these cells [21]. This cytokine also induces 
neutrophi l  degranulat ion and the release of 
lysosomial enzymes and active oxygen species in 
the joint cavity [22]. In this way IL-8 may contr ibute 
to cart i lage degradation. This inhib i tory effect of 
IL-6 on IL-8 product ion can be included in the 
series of protective act ions recent ly described for 
IL-6. In fact, IL-6 st imulates T IMP product ion by 
chondrocyte wi thout  affecting col lagenase activity 
[36]. Moreover, IL-6 increases TGFfl [19] synthesis 
and stimulates chondrocytes prol i ferat ion [20] but 
does not modify prostaglandin E~ (PGE2), col lagen 
or proteoglycan syntheses [15, 18]. On the other  
hand, together  with the secret ion of IL-6, chondro- 
cytes may contr ibute to the development of 
auto immuni ty  directed toward cart i lage ant igens 
such as type II collagen. In fact, IL-6 is required for 
T-cell activation, B-cell maturat ion and ant ibody 
product ion,  including the rheumato id  factor  
[13, 37]. IL-6 may also contr ibute to the develop- 
ment of the inf lammatory react ion accompany ing  
RA. IL-6 induces acute phase product ion  by 
hepatocytes [25]. Nevertheless, a recent  in vivo 
Table II. 
IL-6 amounts found in the cultured medium and inside chondrocytes cultures in the 
absence or in the presence of increase concentrations of IL-8 
IL-8 '" IL-8 IL-8 
Culture duration Control 2 ng/ml 20 ng/ml 100 ng/ml 
In culture medium 
24 h 18.2 _+ 1.15 14.2 ± 3.2 15.6 ± 5.6 18.6 + 1.15 
48 h 29 ± 2.4 29 _+ 1.8 31.6 _-4- 6 37 _+ 1" 
72 h 35.3 ± 2.5 33.3 ± 4.16 45 ± 4.2 53.3 _ 7.5* 
Inside cell extracts 
24 h 5.1 ± 1 4.9 + 0.1 6.2 ± 0.9 6.2 ± 0.4 
48 h 3.6 _+ 0.2 4.4 ± 0.4 4.3 ± 0.7 5.4 ± 0.9 
72 h 1.03 _+ 0.03 0.99 ± 0.004 2 ± 0.5 1.4 ± 0.19 
Data are the mean -4- S.D. and are expressed inpg per pg of DNA. N= 3 in each group. *Significantly 
different from the control with a P < 0.05. 
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FIG. 5. Time course of inter leukin (IL)-6 production by 
human chondrocytes. Pr imary chondrocytes were cul- 
tured in the absence ( - , - )  or presence of 0.2 ng/ml 
( -A- ) ,  2 ng/ml ( -O- )  or 20 ng/ml ( -O- )  of L IE (a) IL-6 
present inside ce l lu la r  phase. (b) IL-6 released into 
culture medium. Results are the mean values of 
tr ipl icate of primary chondrocytes culture in a represen- 
tative experiment and error bars represent S.D. 
Differences between curves are tested by Zerbe test. 
a ,b¢c :  P<0.025;  a ,b¢d:  P<0.01 ;  c#d:  P<0.05 ;  
e,f ~ g; P < 0.05; e,f ~ h: P < 0.01; g ~ h: P < 0.01. 
study failed to demonstrate the efficacy of anti-IL-6 
treatment in experimental rthritis [38]. 
In the present study, we have also demonstrated 
that chondrocytes produced LIE This production 
was highly increased by pro-inflammatory c t0ki- 
nes such as IL-lfl, TNF~ and IL-6. These results are 
in agreement with previous studies that showed 
that LIF production was induced not only by 
pro-inflammatory c tokines but also by growth 
factors such as TGFfl, platelet-derived growth 
factor (PDGF), insulin-like growth factor (IGF) and 
basic fibroblast growth factor (bFGF) [39]. The role 
played by LIF in the development of articular 
diseases is still obscure. We have previously 
described that LIF decreased proteoglycans pro- 
duction [40]. Together with the observations of 
Lotz et al. [39] that LIF can induce expression of 
collagenase and stromelysin by human articular 
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FIG. 6. Effect of leukemia inhibitory factor (LIF) on (a) 
inter leukin (IL-8) and (b) IL-lfl released into culture by 
human chondrocytes. Cytokine levels were assayed by 
enzyme-amplified sensitivity immunoassay at each time 
point. Values are the mean and S.D. (N= 3). Statist ical 
analysis is performed with unpaired Student's t-test for 
assessing significant differences between controls and 
treated groups: **P < 0.01; ***P < 0.001. 
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Fro. 7. Leukemia inhibitory factor (LIF) induction of interleukin (IL)-6 is mediated by IL-1. During 48 h, primary 
chondrocytes cultures were simultaneously incubated with LIF (20 ng/ml) and specific antibodies neutralizing IL-I~ and 
fl activities (Pab IL-1), or with LIF (20 ng/ml) or specific neutralizing antibodies only. IL-6 was directly assayed in the 
culture medium by specific enzyme-amplified sensitivity immunoassay. Results are expressed as mean values from one 
representative experiment performed in triplicate. Statistical significance: a ~ b ve c P < 0.05. • = controls; [] = Pab 
5/~g/ml; [] = Pab 10 #g/ml; [] = LIF 20 ng/ml; [] = LIF 20 ng/ml + Pab 5 #g/mL; [] = LIF 20 ng/ml + Pab 10 #g/ml. 
chondrocytes wi thout  affect ing T IMP product ion,  
L IF  appears to be a potent  mediator  of cart i lage 
resorpt ion [32]. Furthermore,  we have shown that 
L IF  st imulated product ion of pro- inf lammatory 
cytokines including IL-6, IL-8 and IL-lfl. These 
observations support  the not ion that  L IF  may be 
directly or indirect ly involved in the development 
of cart i lage destruct ion and the process of jo int  
inf lammatory events. The finding that L IF  induced 
IL-lfl product ion by chondrocytes suggested that  
the L IF  effect could be mediated indirect ly by IL-1. 
To verify this hypothesis, chondrocytes were 
Table III. 
Quantitation of cytokines (IL-6, IL-8, LIF) present~in free cell supernatants after 48 h of 
culture with culture medium, purified antibodies neutralizing LIF activities (Pab LIF), IL-lfl 
only or simultaneously with Pab LIF and IL-lfl 
Parameters Pab LIF IL-lfl IL-lfl 17 ng/ml 
studied Control 50 #g/ml 17 ng/ml Pab LIF 50 pg/ml 
IL-6 
pg/pg DNA 509 _ 47a 234 + 5b* 7774 ± 1499c*** 8138 + 272c*** 
IL-8 
pg/#g DNA 2909 _+ l13a 2748 _+ 137a 11093 _+ 129b** 13881 _ 1100c*** 
LIF 
pg/#g DNA 890 _+ 17.6a Not detectable 2987 + 234b** Not detectable 
Letters indicate differences between treated and untreated groups. *P < 0.05; **P < 0.01; 
***P < 0.001. 
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Table IV. 
The negative and positive effects of the different 
cytokines on each other 
Cytokines assayed 
Cytokines added IL-6 IL-8 LIF IL-lfl 
IL-lfl + + + ND 
TNF~ + + + ND 
IL-6 ND - + ND 
IL-8 + ND 0 ND 
LIF + + ND + 
+ = stimulation; - = inhibition; 0 -- no effect; ND = Not 
determined. 
cu l tured in the presence of ant ibodies neutra l iz ing 
IL - la  and fl activit ies. We observed that  LIF-in- 
duced IL-6 and IL-8 product ions  are tota l ly  
inhib i ted by ant ibodies neutra l i z ing  IL- I~ and 
IL-lf l  activit ies. This f inding provides evidence that  
L IF  effects are secondary  at the re lease of IL-1. 
This hypothes is  is suppor ted  by the observat ion 
that  L IF  induced a rapid secret ion of IL-lf l  which 
occurred wi th in  30 min, before the induct ion of 
IL-8 and IL-6. Interest ingly,  the addit ion of 
ant ibodies neutra l iz ing L IF  act iv i ty in the cu l ture 
medium decreased signif icant ly the spontaneous  
IL-6 product ion  but did not modify the effect of 
IL- l f l  on this parameter .  These results  suggest hat  
L IF  and IL-lf l  are not  synergic. 
In summary  (Table IV), IL-lf i  and TNF~ are 
potent  inducers  of the product ion  of pro- inf lamma- 
tory cytokines.  These latter  cytok ines may in teract  
to regu late  the i r  product ions  by chondrocytes.  We 
have clearly identif ied the fol lowing interact ions.  
IL-6 decreases IL-8 product ion and sl ight ly in- 
creases L IF  synthesis.  IL-8 have a moderate  
s t imulatory  effect on IL-6 product ion  but does not  
effect L IF  product ion.  Finally, L IF  is a potent  
s t imulant  o induce cytokines product ion,  such as 
IL-lfl, IL-6 and IL-8. Nevertheless,  these effects are 
l ikely to be mediated by, and secondary  to, IL-1 
secret ion.  In conclusion, our  study suggests  that  
th rough the product ion  of cytokines,  chondrocytes 
may act  on  ne ighbour ing  connect ive t issue metab- 
ol ism and init iate and modulate  the in f lammat ion 
and immune responses. These product ions  are 
regu lated by a complex interact ive network  of 
mediators.  
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